prime health glp-1 Doctor Consult Prime continues to lead industry

A dose-dependent superiority in lowering HbA 1c was evident with all three tirzepatide doses vs all comparators, with mean differences ranging from 17.71 mmol/mol (1.62%) to 22.35 mmol/mol (2.06%) vs placebo, 3.22 mmol/mol (0.29%) to 10.06 mmol/mol (0.92%) vs GLP-1 RAs, and 7.66 mmol/mol (0.70%) to 12.02 mmol/mol (1.09%) vs basal insulin regimens

GLP-1 receptor agonists: data protection and patent expiry GLP-1 drugs are protected by both data exclusivity and patents

We excluded studies on drug-drug interactions between GLP1RAs and anti-hyperglycemic medications

Gel packs for medication cooling are allowed through TSA security regardless of the liquid restrictions

There is also a theoretical risk that excessive antioxidants could interfere with the body's natural ability to signal for repair